Research location
Asnières-sur-Seine
France
Advertisement
Research activity in Asnières-sur-Seine
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Asnières-sur-Seine
10 linked trials · page 1 of 1A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthlyNCT03809325 · 2018-11-21 · 1 site observation
COMPLETED
Evaluation of the Frequency of Limitation of Activity in Patients With Persistent AsthmaNCT01078688 · 2010-03-01 · 1 site observation
COMPLETED
Evaluation of Target Organs Impairment on Patients Suffering From High Blood PressureNCT00925470 · 2009-06-01 · 1 site observation
COMPLETED
Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational StudyNCT00909038 · 2009-05-01 · 1 site observation
COMPLETED
Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)NCT00882128 · 2009-05-01 · 1 site observation
COMPLETED
National Survey on HypertensionNCT00804167 · 2008-12-01 · 1 site observation
COMPLETED
National Survey on Coronary Patients and Heart Failure Performed in 2 Patient GroupsNCT00699959 · 2008-06-01 · 1 site observation
COMPLETED
National Survey on Hypertension in Cardiologic Private PracticeNCT00695175 · 2008-02-01 · 1 site observation
COMPLETED
Local Phase 4 Pan-European SMART StudyNCT00463866 · 2007-03-01 · 1 site observation
COMPLETED
Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular PressureNCT00230763 · 2005-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.